FIRST RESULTS OF CROSS-SECTIONAL RESEARCH OF MILD COGNITIVE IMPAIRMENT AND DEMENTIA OF PERSONS OF 60 YEARS AND OLDER HELD ON THE BASIS OF NINE CITY POLYCLINICS OF ALMATY CITY
Data on the prevalence of mild cognitive impairment (MCI) and dementia are absent in Central Asia, particularly in Kazakhstan. Mild cognitive impairment is an intermediate stage between normal aging and dementia. The prevalence of mild cognitive impairment (MCI) varies from 16% to 20%, indicating a high risk of transformation from MCI into dementia. 46.8 million people suffer from dementia. 5.2% are people over the age of 60. Object of the study: To reveal the prevalence of mild cognitive impairment and dementia in people 60 years and older in the nine city polyclinics (CP №3, CP №4, CP №13, CP №18, CP №21, CP № 22, CP № 27, CP №29, CP №34) in Almaty. Materials and methods: The cross-sectional study on the detection of mild cognitive impairment and dementia, which was conducted since September 4, 2017 up to October 31, 2017. 236 respondents aged 60 years and over were included. Primary material was collected using the CHAMP Clinic Questionnaire (Australia, School of Public Health), the MOCA test, a short scale for assessing depression and measuring blood pressure. Results: There were light cognitive impairments - 52.12% (123 respondents), mild cognitive impairment - 33.05% (78 respondents), no impairments - 14.41% (34 respondents) and 0.42% (1 respondent) with a syndrome of dementia were revealed. Conclusion: Since Kazakhstan belongs to middle-income countries and it has the growing trend of the aging population, it is urgent for us to continue screening the population for the detection of MCI and dementia, with the further goal of prevention and treatment.